Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
MC.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LP.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.50.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
MH.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MA.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.1.5.81SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CH.1.1.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBL.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.28.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GA.6.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.61SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FR.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.2.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.25SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.33SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GP.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.7.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.1.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDYSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.18.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.4.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KS.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.21SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JC.5.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XDPSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.2.3.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.2.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LU.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LF.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LB.1.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MM.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used